<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab4">
 <label>Table 4</label>
 <caption>
  <p>Diagnostics recommendations for suspected viral encephalitis/meningoencephalitis</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>CMG</th>
    <th>Differential diagnostic recommendations</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>IEC*</td>
    <td>
     <p>Children: HSV-1, HSV-2, enteroviruses, EBV, parechovirus (&lt; 3 years), 
      <italic>Mycoplasma pneumoniae,</italic> TBEV, WNV (S. Europe), TOSV (S. Europe)
     </p>
     <p>Adults: HSV-1, HSV-2, enteroviruses, VZV
      <italic>, Treponema pallidum</italic>, 
      <italic>Cryptococcus</italic>, HIV, TBEV, WNV (S. Europe), TOSV (S. Europe)
     </p>
     <p>Others based on epidemiological and clinical features.</p>
    </td>
   </tr>
   <tr>
    <td>EFNS
     <sup>^</sup>
    </td>
    <td>Unspecified: HSV-1, HSV-2, VZV, HHV 6/7, CMV, EBV, JCV, Dengue virus, respiratory viruses, RSV, HIV, adenovirus, influenza A and B, rotavirus
     <italic>, Coxsackie B5</italic>, non-typed enterovirus, 
     <italic>Parainfluenza 1</italic> virus
    </td>
   </tr>
   <tr>
    <td>DNS</td>
    <td>Unspecified: HSV, VZV, HIV, EBV/CMV, syphilis, HHV 6–7, toxoplasma</td>
   </tr>
   <tr>
    <td>DGN: VM</td>
    <td>
     <p>Unspecified: HSV, VZV, CMV, coxsackievirus, echovirus, adenovirus, phlebovirus, measles, TBE, mumps, EBV, rubella, enterovirus 71, HIV, parvovirus B19, HHV-6, Dengue virus, FSME, rabies, vaccinia, Lassa virus, Japanese encephalitis, WNV, polioviruses, hantavirus, filovirus</p>
     <p>Others based on epidemiological and clinical features.</p>
    </td>
   </tr>
   <tr>
    <td>IDSA*</td>
    <td>
     <p>Neonates: HSV 2, CMV, rubella virus, 
      <italic>L. monocytogenes, T. pallidum, Toxoplasma gondii</italic>
     </p>
     <p>Infants and Children: 
      <italic>Eastern equine encephalitis virus, Japanese encephalitis virus, Murray</italic>
     </p>
     <p>
      <italic>Valley encephalitis virus</italic>, influenza virus, 
      <italic>La Crosse virus</italic>
     </p>
     <p>Unspecified: HSV, WNV, TBEV, 
      <italic>A. phagocytophilum, B.burgdorferi</italic>
     </p>
     <p>Elderly: 
      <italic>Eastern equine encephalitis virus, St. Louis encephalitis virus,</italic> WNV, sporadic Creutzfeldt-Jakob Disease, 
      <italic>L. monocytogenes</italic>
     </p>
     <p>Person-to-person transmission: VZV, 
      <italic>Venezuelan equine encephalitis virus</italic> (rare), poliovirus, non-polio enteroviruses, measles virus
      <italic>,</italic> mumps virus, rubella virus, EBV, HHV 6, B virus, WNV (transfusion transplantation, breast feeding), HIV, 
      <italic>Nipah virus</italic>, rabies virus (transplantation), influenza virus, 
      <italic>M. pneumoniae, Mycobacterium tuberculosis, T. pallidum.</italic>
     </p>
     <p>Others based on specific clinical findings, epidemiology and risk factors.</p>
    </td>
   </tr>
   <tr>
    <td>PHE: VE*</td>
    <td>
     <p>Children and adults: HSV-1, HSV-2, VZV, enteroviruses, parechovirus (&lt; 3 years), HHV-6 (&lt; 3 years), mumps (if epidemic), Influenza A, B (if epidemic), HIV,</p>
     <p>Others based on specific epidemiology and risk factors</p>
    </td>
   </tr>
   <tr>
    <td>BIA/ABN</td>
    <td>
     <p>Adults: HSV-1, HSV-2, VZV, enteroviruses, parechovirus, measles virus, mumps virus, TBEV (eastern Europe), WNV (southern Europe), HIV, EBV (immunocompromised), CMV (immunocompromised) influenza virus (rare), adenovirus (rare), 
      <italic>Erythrovirus B19</italic> (rare), lymphocytic choreomeningitis virus (rare), rubella virus (rare)
     </p>
     <p>Others based on epidemiological and clinical features.</p>
    </td>
   </tr>
   <tr>
    <td>BIA/ABN/BPAIIG</td>
    <td>
     <p>Children: HSV-1, HSV-2, VZV, enteroviruses, parechovirus
      <italic>,</italic> HHV 6/7, measles virus, mumps virus, rotavirus, HIV, TBEV (eastern Europe), WNV (southern Europe), HIV, EBV (immunocompromised), CMV (immunocompromised) influenza virus (rare), adenovirus (rare), 
      <italic>Erythrovirus B19</italic> (rare), lymphocytic choreomeningitis virus (rare), rubella virus (rare)
     </p>
     <p>Others based on epidemiological and clinical features.</p>
    </td>
   </tr>
   <tr>
    <td>AEPED*</td>
    <td>
     <p>Congenital: 
      <italic>Lymphocytic Choriomeningitis virus,</italic> CMV, measles virus, 
      <italic>T. gondii, T. pallidum,</italic>
     </p>
     <p>Neonates (&lt; 1 month): HSV, enteroviruses, adenovirus, 
      <italic>Citrobacter</italic> spp., GBS, 
      <italic>L. monocytogenes</italic>
     </p>
     <p>Infants and children &gt; 1 month: HSV, enteroviruses, arboviruses, EBV, adenovirus, HIV, 
      <italic>M. pneumoniae</italic>, 
      <italic>Borrelia burgdorferi</italic>, 
      <italic>Bartonella henselae</italic>, 
      <italic>Rickettsia rickettsii.</italic>
     </p>
     <p>Others based on epidemiological and clinical features.</p>
    </td>
   </tr>
   <tr>
    <td>SPILF*
     <sup>^</sup>
    </td>
    <td>Adults (metropolitan France): HSV, VZV, HIV, enterovirus, 
     <italic>L. monocytogenes (higher risk &gt; 65 years)</italic>, 
     <italic>M. tuberculosis (higher risk &gt; 75 years)</italic>
    </td>
   </tr>
   <tr>
    <td>NNF*</td>
    <td>
     <p>Unspecified: HSV-1, HSV-2, VZV, EBV, HHV-6, enteroviruses
      <italic>,</italic> parechovirus (children), adenovirus, 
      <italic>Influenza A</italic>, measles, mumps, rubella, HIV, 
      <italic>Hepatitis E</italic>, 
      <italic>Japanese B</italic>, WNV, rabies virus, TBE, 
      <italic>Eastern equine encephalitis</italic>, 
      <italic>S. pneumoniae</italic>, 
      <italic>B. burgdorferi</italic>, 
      <italic>M. pneumoniae</italic>, 
      <italic>Chlamydia trachomatis</italic>, 
      <italic>L. monocytogenes</italic>, 
      <italic>M. tuberculosis</italic>, cerebral malaria, Cystericosis.
     </p>
     <p>Others based on immune status.</p>
    </td>
   </tr>
   <tr>
    <td>PHE: ME*</td>
    <td>Unspecified: HIV, HSV-1, HSV-2, VZV, enteroviruses, parechovirus (&lt; 3 years), 
     <italic>N. meningitidis</italic>, 
     <italic>S. pneumoniae</italic>, 
     <italic>H. influenzae</italic>, 
     <italic>E. coli, L. monocytogenes</italic>, GBS
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>Abbreviations</italic>: 
   <italic>HSV</italic> Herpes simplex virus, 
   <italic>VZV</italic> Varicella-zoster virus, 
   <italic>HIV</italic> human immunodeficiency virus, 
   <italic>HHV</italic> human herpesvirus, 
   <italic>CMV</italic> Cytomegalovirus, 
   <italic>EBV</italic> Epstein-Barr virus, 
   <italic>RSV</italic> respiratory syncytial virus, 
   <italic>TBEV</italic> tick-borne encephalitis virus, 
   <italic>WNV</italic> West Nile virus, 
   <italic>JEV</italic> Japanese encephalitis virus, 
   <italic>IEC</italic> International Encephalitis Consortium, 
   <italic>EFNS</italic> European Federation of Neurological Societies, 
   <italic>DNS</italic> Dansk Neurologisk Selskab, 
   <italic>DGN: VM</italic> Deutsche Gesellschaft für Neurologie: Virale Meningoeczephalitis, 
   <italic>PHE: VE</italic> Public Health England:Viral Encephalitis, 
   <italic>BIA: ABN</italic> British Infection Association: Association of British Neurologists, 
   <italic>BPAIIG</italic> The British Paediatric Allergy Immunology and Infections Group, 
   <italic>AEPED</italic> Asociación Española de Pediatría, 
   <italic>SPILF</italic> Société de Pathologie Infectieuse de Langue Française, 
   <italic>NNF</italic> Norsk Nevrologisk Forening, 
   <italic>PHE: ME</italic> Public Health England: Meningoencephalitis
  </p>
  <p>*Includes non-viral differential diagnostic recommendations</p>
  <p>
   <sup>^</sup>Differential diagnostic recommendations not clearly defined
  </p>
 </table-wrap-foot>
</table-wrap>
